2023
DOI: 10.1007/s00059-022-05156-0
|View full text |Cite
|
Sign up to set email alerts
|

Herzinsuffizienz mit erhaltener Ejektionsfraktion (HFpEF)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…Heart failure with preserved ejection fraction (HFpEF) is a growing epidemic because of the increasingly obese and aging patient population, characterized by a high prevalence of patients with multiple comorbidities. 1 HFpEF is a clinical syndrome with multiple contributing risk factors, causes (such as arterial hypertension, pulmonary hypertension, plasma volume expansion, systemic microvascular inflammation, cardiometabolic functional abnormalities, and cellular/extracellular structural abnormalities), and phenotypic manifestations. 2 Although it is widely prevalent, the diagnosis of HFpEF remains challenging, despite advances in cardiac biomarkers, noninvasive imaging modalities, and provocative testing (e.g.…”
mentioning
confidence: 99%
“…Heart failure with preserved ejection fraction (HFpEF) is a growing epidemic because of the increasingly obese and aging patient population, characterized by a high prevalence of patients with multiple comorbidities. 1 HFpEF is a clinical syndrome with multiple contributing risk factors, causes (such as arterial hypertension, pulmonary hypertension, plasma volume expansion, systemic microvascular inflammation, cardiometabolic functional abnormalities, and cellular/extracellular structural abnormalities), and phenotypic manifestations. 2 Although it is widely prevalent, the diagnosis of HFpEF remains challenging, despite advances in cardiac biomarkers, noninvasive imaging modalities, and provocative testing (e.g.…”
mentioning
confidence: 99%